The 2018 paper in Biochemical Pharmacology gave obese mice a membrane-permeable NNMT inhibitor and reported it significantly reduced body weight and white adipose mass, decreased adipocyte size, with the mice eating the same amount as before, and the authors noting the inhibitors did not impact total food intake nor produce any observable adverse effects [1]
This is a good choice for patients on higher doses of Tirzepatide or in states with less options
Consistency: Keep a consistent dosing time each day
Thereby, the Nos3Nos1Nos2 interplay after BPC 157 influences Nos3 may enhance Nos3 activity in functions such as regulating cerebral microvascular tone, protecting the bloodbrain barrier, reducing oxidative stress, and alleviating procoagulant stimulation (Chen, Mou, Feng, Wang, & Chen, 2017)
She reported infrequent stiffness, but not as severe as it was prior to treatment